Matsukawa Y, Lee V H, Crandall E D, Kim K J
Department of Pharmaceutical Sciences, University of Southern California, Los Angeles 90033, USA.
J Pharm Sci. 1997 Mar;86(3):305-9. doi: 10.1021/js960352x.
The transport of dextrans (approximately 4 to approximately 150 kDa) across an in vitro model of the alveolar epithelial barrier was studied to determine the effects of molecular size on pulmonary absorption of macromolecular drugs. Fluorescein isothiocyanate (FITC)-labeled dextrans (FDs) with average molecular weights (all in kDa) of 3.86 (FD4), 9 (FD10), 19.8 (FD20), 40.5 (FD40), 71.6 (FD70), and 156.9 (FD150) were utilized as model macromolecular drugs. Unidirectional fluxes of FDs at 37 and 4 degrees C were measured from the appearance rates of FD in the receiver fluid of open-circuited monolayers (>2000 omega-cm2) of rat alveolar epithelial cells. Apparent permeability coefficients (P(app)) were estimated from the observed flux and the corresponding concentration gradient of FD. Results showed that FD fluxes were the same in both apical-to-basolateral (AB) and opposite (BA) directions at each molecular weight studied. The P(app) was not significantly different at 0.5 and 1.0 mg/mL FD40 donor concentrations. The FD P(app) (x 10(-8)cm/s) decreased gradually from 1.35 for FD4 to 0.32 for FD40, indicating an apparent inverse relationship between P(app) and molecular weight of FD. By contrast, P(app) was about the same at 0.13 for both FD70 and FD150. When experimental temperature was lowered to 4 degrees C, P(app) decreased by approximately 40% for FDs of 4 through 40 kDa, whereas the decrease in P(app) was by approximately 80% for larger FDs of both 70 and 150 kDa. Moreover, these FDs were found to be relatively intact (approximately 90%) in either receiver fluid after 5-h flux experiments without detectable levels of metabolites in the respective donor fluid, suggesting that alveolar epithelial cells allow translocation of FDs intact across the barrier. Equivalent pore analysis, assuming restricted diffusion of FDs of 4-40 kDa via cylindrical, water-filled pores across the cell monolayer revealed a population of large equivalent pores with approximately 5.6 nm radius. These data suggest that smaller macromolecules (radius <5 nm) traverse the alveolar epithelial barrier via paracellular pathways, and that larger (i.e., radius > or = 6 nm) macromolecules likely cross the barrier via other pathways (e.g., pinocytosis).
研究了葡聚糖(分子量约4至约150 kDa)在肺泡上皮屏障体外模型中的转运,以确定分子大小对大分子药物肺部吸收的影响。使用平均分子量(均以kDa计)为3.86(FD4)、9(FD10)、19.8(FD20)、40.5(FD40)、71.6(FD70)和156.9(FD150)的异硫氰酸荧光素(FITC)标记的葡聚糖(FDs)作为模型大分子药物。在37℃和4℃下,从大鼠肺泡上皮细胞开路单层(>2000Ω·cm²)的接收液中FD的出现速率测量FDs的单向通量。根据观察到的通量和FD的相应浓度梯度估算表观渗透系数(P(app))。结果表明,在所研究的每个分子量下,FD在顶侧到基底侧(AB)和相反方向(BA)的通量相同。在0.5和1.0 mg/mL的FD40供体浓度下,P(app)没有显著差异。FD的P(app)(×10⁻⁸cm/s)从FD4的1.35逐渐降低到FD40的0.32,表明P(app)与FD的分子量之间存在明显的反比关系。相比之下,FD70和FD150的P(app)约为0.13。当实验温度降至4℃时,4至40 kDa的FD的P(app)降低约40%,而70和150 kDa较大FD的P(app)降低约80%。此外,在5小时通量实验后,发现这些FD在接收液中相对完整(约90%),各自供体液中未检测到代谢产物水平,这表明肺泡上皮细胞允许FD完整地穿过屏障。等效孔分析假设4至40 kDa的FD通过充满水的圆柱形孔在细胞单层中受限扩散,揭示了一群半径约为5.6 nm的大等效孔。这些数据表明,较小的大分子(半径<5 nm)通过细胞旁途径穿过肺泡上皮屏障,而较大的(即半径≥6 nm)大分子可能通过其他途径(如胞饮作用)穿过屏障。